Effects of a group-based weight management programme on anxiety and depression: A randomised controlled trial (RCT).
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
01
2021
accepted:
09
01
2022
entrez:
3
2
2022
pubmed:
4
2
2022
medline:
1
3
2022
Statut:
epublish
Résumé
The aim was to investigate the impact of a group-based weight management programme on symptoms of depression and anxiety compared with self-help in a randomised controlled trial (RCT). People with overweight (Body Mass Index [BMI]≥28kg/m2) were randomly allocated self-help (n = 211) or a group-based weight management programme for 12 weeks (n = 528) or 52 weeks (n = 528) between 18/10/2012 and 10/02/2014. Symptoms were assessed using the Hospital Anxiety and Depression Scale, at baseline, 3, 12 and 24 months. Linear regression modelling examined changes in Hospital Anxiety and Depression Scale between trial arms. At 3 months, there was a -0.6 point difference (95% confidence interval [CI], -1.1, -0.1) in depression score and -0.1 difference (95% CI, -0.7, 0.4) in anxiety score between group-based weight management programme and self-help. At subsequent time points there was no consistent evidence of a difference in depression or anxiety scores between trial arms. There was no evidence that depression or anxiety worsened at any time point. There was no evidence of harm to depression or anxiety symptoms as a result of attending a group-based weight loss programme. There was a transient reduction in symptoms of depression, but not anxiety, compared to self-help. This effect equates to less than 1 point out of 21 on the Hospital Anxiety and Depression Scale and is not clinically significant.
Identifiants
pubmed: 35113940
doi: 10.1371/journal.pone.0263228
pii: PONE-D-21-01460
pmc: PMC8812921
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0263228Subventions
Organisme : Medical Research Council
ID : MC_EX_MR/J000493/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J000493/1
Pays : United Kingdom
Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests: PA and SAJ are investigators on an investigator-initiated trial funded by Cambridge Weight Plan.PA has presented at two symposia on behalf of the Royal College of General Practitioners that were sponsored by Novo Nordisk. ALA is lead investigator on two publicly funded investigator-initiated trials where the intervention is provided by WW at no cost. None of these activities led to payments to the individuals named. This does not alter our adherence to PLOS One policies on sharing data and materials.
Références
Arch Intern Med. 2009 Jan 26;169(2):163-71
pubmed: 19171813
Obes Res. 2005 May;13(5):907-16
pubmed: 15919845
Lancet. 2017 Jun 3;389(10085):2214-2225
pubmed: 28478041
Int J Obes (Lond). 2011 Nov;35(11):1363-76
pubmed: 21343903
PLoS One. 2014 Aug 06;9(8):e104552
pubmed: 25098417
J Med Virol. 2021 Jan;93(1):257-261
pubmed: 32603481
J Health Psychol. 2007 Jan;12(1):66-82
pubmed: 17158841
Lancet Diabetes Endocrinol. 2015 Feb;3(2):114-22
pubmed: 25483220
Curr Obes Rep. 2015 Sep;4(3):303-10
pubmed: 26627487
Br J Gen Pract. 2016 Apr;66(645):e258-63
pubmed: 26906629
Int J Obes (Lond). 2011 Jul;35(7):891-8
pubmed: 20975725
Cardiovasc Diabetol. 2020 Nov 3;19(1):187
pubmed: 33143700
Nature. 2006 Dec 14;444(7121):875-80
pubmed: 17167476
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
PLoS Med. 2016 Aug 16;13(8):e1002081
pubmed: 27529652
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
BMC Public Health. 2014 Jun 18;14:620
pubmed: 24943673
BMC Public Health. 2011 Jun 06;11:434
pubmed: 21645343
Mol Psychiatry. 2019 Jan;24(1):18-33
pubmed: 29453413
Obes Rev. 2021 Apr;22(4):e13150
pubmed: 33103340
Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-359
pubmed: 33932335
J Clin Epidemiol. 2005 Jun;58(6):568-78
pubmed: 15878470
Obes Rev. 2014 Mar;15(3):169-82
pubmed: 24118750
Obes Rev. 2007 Mar;8 Suppl 1:13-7
pubmed: 17316295
PLoS One. 2009 Aug 13;4(8):e6624
pubmed: 19675667